Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) (Q58414415)
Jump to navigation
Jump to search
scientific article published on 25 April 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) |
scientific article published on 25 April 2006 |
Statements
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) (English)
Martin Bornhäuser
1 reference
Albrecht Reichle
Dieter Hoelzer
Barbara Wassmann
Heike Pfeifer
Nicola Goekbuget
Dietrich W Beelen
Joachim Beck
Matthias Stelljes
Jolanta Perz
Rainer Haas
Arnold Ganser
Mathias Schmid
Lothar Kanz
Georg Lenz
Martin Kaufmann
Anja Binckebanck
Patrick Brück
Regina Reutzel
Harald Gschaidmeier
Stefan Schwartz